SATELLOS BIOSCIENCE INC.
Ownership & governance
Executives 5Directors 9Avg age 60Avg tenure 4.8y
FG
Frank Gleeson
Chief Executive Officer
Age 70Since 2018-02-28Profile →
+13
Executives5
FG
Frank Gleeson→
Chief Executive Officer
Age 70Since 2018-02-28
MR
Michael Rudnicki→
Chief Tech/Sci/R&D Officer
—Since 2018-04-30
EW
Elizabeth Williams→
Director of Finance/CFO
—Since 2023-08-31
WF
Wildon Farwell→
Chief Tech/Sci/R&D Officer
Age 51Since 2025-07-15
PL
Philip Lambert→
Chief Tech/Sci/R&D Officer
Age 58Since 2022-09-26
Board of directors9
GM
Geoff MacKay→
Chairman
Age 59Since 2018-06-30
BB
Brian Bloom→
Director/Board Member
Age 50Since 2018-02-28
FG
Frank Gleeson→
Director/Board Member
Age 70Since 2012-06-30
AM
Adam Mostafa→
Director/Board Member
Age 46Since 2021-12-04
FB
Franklin Berger→
Director/Board Member
Age 76Since 2023-06-28
SB
Stephanie Brown→
Director/Board Member
—Since 2024-11-13
IL
Iris Löw-Friedrich→
Director/Board Member
Age 65Since 2025-06-17
SH
Selwyn Ho→
Director/Board Member
Age 55Since 2025-06-17
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Qiming US Ventures Management, LLC | 8.282 % | 1,725,247 |
| Brian Bloom | 5.441 % | 1,133,400 |
| Franklin Advisers, Inc. | 4.506 % | 938,666 |
| The Invus Group LLC | 4.282 % | 892,074 |
| The Invus Group LLC | 4.282 % | 892,074 |
Catalog · 2026-07-09
Registry officers14
| Name | Role | Since | Shares |
|---|---|---|---|
| Elizabeth Williams | Director of Finance/CFO | 2023-08-31 | - |
| Frank Gleeson | Chief Executive Officer | 2018-02-28 | - |
| Geoff MacKay | Chairman | 2018-06-30 | - |
| Michael Rudnicki | Chief Tech/Sci/R&D Officer | 2018-04-30 | - |
| Philip Lambert | Chief Tech/Sci/R&D Officer | 2022-09-26 | - |
| Wildon Farwell | Chief Tech/Sci/R&D Officer | 2025-07-15 | - |
| Adam Mostafa | Director/Board Member | 2021-12-04 | - |
| Brian Bloom | Director/Board Member | 2018-02-28 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus noneMean target 17.47Range 16–19Analysts 3
16Mean 17.4719
- Strong buy 2
- Buy 1
Broker actions8
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Craig-Hallum | Initiated | Buy | 24 | 2026-10-08 |
| HC Wainwright & Co. | Reiterated | Buy | 18 | 2026-08-17 |
| HC Wainwright & Co. | Maintained | Buy | 18 | 2026-07-09 |
| HC Wainwright & Co. | Reiterated | Buy | 11 | 2026-05-18 |
| Guggenheim | Initiated | Buy | 23 | 2026-04-28 |
| Leerink Partners | Initiated | Outperform | 20 | 2026-04-06 |
| HC Wainwright & Co. | Maintained | Buy | 11 | 2026-03-30 |
| Cantor Fitzgerald | Initiated | Overweight | — | 2026-03-11 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.